Skip to main content
Equibles

Phil Naddow

Analyst

TD Cohen

Equibles does not estimate personal net worth.

About Phil Naddow

Phil Naddow is recorded as Analyst at TD Cohen. Phil Naddow has spoken on 1 investor event across 1 company, most recently for Kura Oncology, Inc. on October 13, 2026. The companies whose calls Phil Naddow spoke on are classified in the Healthcare sector.

Phil Naddow on recent calls

“Can you talk a little bit more about how you will figure out who are the ideal patients in terms of residual beta cell capacity, endogenous insulin production?”
Analyst — TD Cohen, Kura Oncology EASD Virtual Investor Event ·

Affiliation history

  • TD Cohen

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity